S&P 500   3,377.36 (+0.50%)
DOW   28,056.82 (+0.95%)
QQQ   270.22 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,377.36 (+0.50%)
DOW   28,056.82 (+0.95%)
QQQ   270.22 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,377.36 (+0.50%)
DOW   28,056.82 (+0.95%)
QQQ   270.22 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,377.36 (+0.50%)
DOW   28,056.82 (+0.95%)
QQQ   270.22 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
Log in

NASDAQ:ACERAcer Therapeutics News Headlines

Add
Compare
Today's Range N/A
50-Day Range
$3.11
MA: $3.52
$5.41
52-Week Range N/A
Volume3.02 million shs
Average Volume511,425 shs
Market Capitalization$55.45 million
P/E RatioN/A
Dividend YieldN/A
Beta1.82

Headlines

Acer Therapeutics (NASDAQ ACER) News Headlines

Source:
DateHeadline
Acer Therapeutics Inc (NASDAQ:ACER) Sees Large Drop in Short InterestAcer Therapeutics Inc (NASDAQ:ACER) Sees Large Drop in Short Interest
americanbankingnews.com - August 8 at 1:20 AM
Short Interest in Acer Therapeutics Inc (NASDAQ:ACER) Decreases By 7.5%Short Interest in Acer Therapeutics Inc (NASDAQ:ACER) Decreases By 7.5%
americanbankingnews.com - August 4 at 3:44 AM
Acer Therapeutics (NASDAQ:ACER) Stock Price Up 6.7%Acer Therapeutics (NASDAQ:ACER) Stock Price Up 6.7%
americanbankingnews.com - August 3 at 8:28 PM
Insider Weekends: Another Purchase In The Energy SectorInsider Weekends: Another Purchase In The Energy Sector
seekingalpha.com - August 3 at 7:57 AM
-$0.38 Earnings Per Share Expected for Acer Therapeutics Inc (NASDAQ:ACER) This Quarter-$0.38 Earnings Per Share Expected for Acer Therapeutics Inc (NASDAQ:ACER) This Quarter
www.americanbankingnews.com - August 3 at 4:18 AM
Acer Therapeutics (NASDAQ:ACER) Trading Up 11.3% After Insider Buying ActivityAcer Therapeutics (NASDAQ:ACER) Trading Up 11.3% After Insider Buying Activity
www.americanbankingnews.com - July 28 at 6:46 PM
Insider Buying: Acer Therapeutics Inc (NASDAQ:ACER) Insider Buys 14,285 Shares of StockInsider Buying: Acer Therapeutics Inc (NASDAQ:ACER) Insider Buys 14,285 Shares of Stock
www.americanbankingnews.com - July 28 at 3:46 PM
Insider Buying: Acer Therapeutics Inc (NASDAQ:ACER) Director Purchases 45,000 Shares of StockInsider Buying: Acer Therapeutics Inc (NASDAQ:ACER) Director Purchases 45,000 Shares of Stock
www.americanbankingnews.com - July 28 at 3:46 PM
Acer Therapeutics Inc (NASDAQ:ACER) CEO Purchases $499,999.50 in StockAcer Therapeutics Inc (NASDAQ:ACER) CEO Purchases $499,999.50 in Stock
www.americanbankingnews.com - July 28 at 3:46 PM
Tuesday 7/28 Insider Buying Report: ACER, RBCAATuesday 7/28 Insider Buying Report: ACER, RBCAA
www.nasdaq.com - July 28 at 2:18 PM
Insider Buys Acer Therapeuticss SharesInsider Buys Acer Therapeutics's Shares
www.benzinga.com - July 28 at 2:18 PM
Insider Buys Acer Therapeutics's SharesInsider Buys Acer Therapeutics's Shares
finance.yahoo.com - July 28 at 2:18 PM
Acer Therapeutics (NASDAQ:ACER) Shares Pass Above 200-Day Moving Average of $3.25Acer Therapeutics (NASDAQ:ACER) Shares Pass Above 200-Day Moving Average of $3.25
www.americanbankingnews.com - July 28 at 4:47 AM
Shareholder Alert: Robbins LLP Announces the Shareholder Class Action Against Acer Therapeutics Inc. (ACER) Survives Motion to DismissShareholder Alert: Robbins LLP Announces the Shareholder Class Action Against Acer Therapeutics Inc. (ACER) Survives Motion to Dismiss
www.businesswire.com - July 27 at 8:31 PM
Acer Therapeutics (NASDAQ:ACER) Trading Up 12.2%Acer Therapeutics (NASDAQ:ACER) Trading Up 12.2%
www.americanbankingnews.com - July 20 at 7:05 PM
Acer Therapeutics Inc (NASDAQ:ACER) Given Consensus Rating of "Buy" by BrokeragesAcer Therapeutics Inc (NASDAQ:ACER) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 18 at 9:22 AM
Acer Therapeutics Announces Administration of ACER-001 in a Fasted State Increased Systemic Exposure of Phenylbutyrate in Healthy Volunteer Food Effect StudyAcer Therapeutics Announces Administration of ACER-001 in a Fasted State Increased Systemic Exposure of Phenylbutyrate in Healthy Volunteer Food Effect Study
finance.yahoo.com - July 9 at 12:27 PM
Pre-market Movers In Healthcare Sector: INFI, BNGO, ACER, UMRX…Pre-market Movers In Healthcare Sector: INFI, BNGO, ACER, UMRX…
www.nasdaq.com - July 9 at 7:27 AM
BRIEF-Acer Therapeutics Inc Anticipates Submitting ACER-001 NDA In H1 2021BRIEF-Acer Therapeutics Inc Anticipates Submitting ACER-001 NDA In H1 2021
www.reuters.com - July 8 at 8:27 PM
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER)The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER)
finance.yahoo.com - June 24 at 2:16 PM
Acer Therapeutics Discusses Developing COVID-19 Clinical Program, Next Steps with the FDA and Vision for 2020 in New Video Interview on SNN NetworkAcer Therapeutics Discusses Developing COVID-19 Clinical Program, Next Steps with the FDA and Vision for 2020 in New Video Interview on SNN Network
finance.yahoo.com - May 21 at 11:14 AM
BRIEF-Acer Therapeutics Reports Q1 Loss Per Share Of $0.49BRIEF-Acer Therapeutics Reports Q1 Loss Per Share Of $0.49
www.reuters.com - May 15 at 12:27 AM
Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate UpdateAcer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 14 at 7:27 PM
BRIEF-Acer Therapeutics Files For Offer And Sale Of Up To 1.84 Million Shares Of Common Stock By The Selling StockholderBRIEF-Acer Therapeutics Files For Offer And Sale Of Up To 1.84 Million Shares Of Common Stock By The Selling Stockholder
www.reuters.com - May 12 at 5:09 PM
Acer to investigate use of emetine in COVID-19Acer to investigate use of emetine in COVID-19
seekingalpha.com - May 12 at 8:09 AM
Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of HealthAcer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of Health
finance.yahoo.com - May 11 at 5:05 PM
Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park CapitalAcer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park Capital
finance.yahoo.com - April 30 at 4:11 PM
Acer Therapeutics Inc.Acer Therapeutics Inc.
www.barrons.com - March 19 at 8:09 AM
Acer Therapeutics EPS misses by $0.03Acer Therapeutics EPS misses by $0.03
seekingalpha.com - March 18 at 7:09 PM
FDA denies Acer appeal of CRLFDA denies Acer appeal of CRL
seekingalpha.com - March 18 at 7:09 PM
BRIEF-Acer Therapeutics Receives Formal Dispute Resolution Request (Fdrr) Response From FDAs Office Of New DrugsBRIEF-Acer Therapeutics Receives Formal Dispute Resolution Request (Fdrr) Response From FDA's Office Of New Drugs
www.reuters.com - March 18 at 7:09 PM
Acer Receives Formal Dispute Resolution Request (FDRR) Response from FDA’s Office of New DrugsAcer Receives Formal Dispute Resolution Request (FDRR) Response from FDA’s Office of New Drugs
finance.yahoo.com - March 18 at 7:09 PM
Acer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateAcer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 18 at 7:09 PM
eSports Platform Planet9 Now Open for Registration at Intel Extreme Masters in KatowiceeSports Platform Planet9 Now Open for Registration at Intel Extreme Masters in Katowice
finance.yahoo.com - February 26 at 8:01 AM
Play Like the Pros with the Official Predator IEM PCsPlay Like the Pros with the Official Predator IEM PCs
finance.yahoo.com - February 25 at 9:11 AM
Acer Therapeutics Announces ACER-001 for Urea Cycle Disorders Trial Shows Bioequivalence to BUPHENYL®Acer Therapeutics Announces ACER-001 for Urea Cycle Disorders Trial Shows Bioequivalence to BUPHENYL®
finance.yahoo.com - February 24 at 7:05 PM
Heres Why Were A Bit Worried About Acer Therapeuticss (NASDAQ:ACER) Cash Burn SituationHere's Why We're A Bit Worried About Acer Therapeutics's (NASDAQ:ACER) Cash Burn Situation
finance.yahoo.com - January 5 at 5:12 PM
Here's Why We're A Bit Worried About Acer Therapeutics's (NASDAQ:ACER) Cash Burn SituationHere's Why We're A Bit Worried About Acer Therapeutics's (NASDAQ:ACER) Cash Burn Situation
finance.yahoo.com - January 5 at 5:12 PM
Hedge Funds Are Betting On Acer Therapeutics Inc. (ACER)Hedge Funds Are Betting On Acer Therapeutics Inc. (ACER)
finance.yahoo.com - December 23 at 6:49 PM
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEOThe Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
www.msn.com - December 17 at 9:13 AM
Acer Therapeutics up 18% after hours on advancement of ACER-001 studyAcer Therapeutics up 18% after hours on advancement of ACER-001 study
seekingalpha.com - December 16 at 6:03 PM
Part A Successfully Completed and Optimal Formulation of ACER-001 IdentifiedPart A Successfully Completed and Optimal Formulation of ACER-001 Identified
www.globenewswire.com - December 16 at 6:03 PM
Acer Therapeutics Announces Full Enrollment of Part B in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle DisordersAcer Therapeutics Announces Full Enrollment of Part B in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders
finance.yahoo.com - December 16 at 6:03 PM
BRIEF-Acer Therapeutics Reports Third Quarter ResultsBRIEF-Acer Therapeutics Reports Third Quarter Results
www.msn.com - November 14 at 12:20 AM
Acer Therapeutics EPS beats by $0.05Acer Therapeutics EPS beats by $0.05
seekingalpha.com - November 13 at 7:19 PM
Acer Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateAcer Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 13 at 7:19 PM
Acer Therapeutics Announces Full Enrollment of Part A in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle DisordersAcer Therapeutics Announces Full Enrollment of Part A in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders
finance.yahoo.com - October 28 at 6:56 PM
27 Stocks Moving in Fridays Pre-Market Session27 Stocks Moving in Friday's Pre-Market Session
www.benzinga.com - October 18 at 8:39 AM
How Much Of Acer Therapeutics Inc. (NASDAQ:ACER) Do Insiders Own?How Much Of Acer Therapeutics Inc. (NASDAQ:ACER) Do Insiders Own?
finance.yahoo.com - October 7 at 10:46 AM
ACER Acer Therapeutics Inc. Common Stock (DE)ACER Acer Therapeutics Inc. Common Stock (DE)
www.nasdaq.com - September 14 at 7:58 AM
This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.